Sanj K. Patel

Companies

• Kiniksa Pharmaceuticals International, plcChief executive officer May 23, 2018 to now¹
• Kiniksa Pharmaceuticals International, plcChair May 23, 2018 to now¹
• Syros Pharmaceuticals, Inc.Board member Jun 29, 2016 to Sep 22, 2017²
• BioCryst PharmaceuticalsBoard member Sep 29, 2015 to May 25, 2017³
• Intercept PharmaceuticalsBoard member Feb 18, 2014 to Jul 21, 2014⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKiniksa Pharmaceuticals International, plc KNSA51,794 shares⁵$4.1M at $79.42Sep 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Shares withheld for tax 15,144 shares at $79.28 of Kiniksa Pharmaceuticals International, plc⁵
• Sep 1, 2026Shares withheld for tax 15,144 shares at $79.28 of Kiniksa Pharmaceuticals International, plc⁶
• Sep 1, 2026Exercised options 8,609 shares of Kiniksa Pharmaceuticals International, plc⁵
• Sep 1, 2026Exercised options 8,609 shares of Kiniksa Pharmaceuticals International, plc⁶
• Sep 1, 2026Exercised options 6,237 shares of Kiniksa Pharmaceuticals International, plc⁵
• Sep 1, 2026Exercised options 6,237 shares of Kiniksa Pharmaceuticals International, plc⁶
• Sep 1, 2026Exercised options 6,481 shares of Kiniksa Pharmaceuticals International, plc⁵
• Sep 1, 2026Exercised options 6,481 shares of Kiniksa Pharmaceuticals International, plc⁶
• Sep 1, 2026Exercised options 9,991 shares of Kiniksa Pharmaceuticals International, plc⁵
• Sep 1, 2026Exercised options 9,991 shares of Kiniksa Pharmaceuticals International, plc⁶
• Jun 1, 2026Converted 900,000 shares of Kiniksa Pharmaceuticals International, plc⁷
• May 1, 2026Sold 48,565 shares at $54.02 of Kiniksa Pharmaceuticals International, plc⁸
• May 1, 2026Exercised options 48,565 shares at $30.93 of Kiniksa Pharmaceuticals International, plc⁸
• Apr 30, 2026Sold 2,141 shares at $54.01 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 30, 2026Exercised options 2,141 shares at $30.93 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 29, 2026Sold 22,544 shares at $54.01 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 29, 2026Exercised options 22,544 shares at $30.93 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Sold 51,750 shares at $54.02 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Sold 243,596 shares at $52.02 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Sold 113,673 shares at $51.47 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Sold 74,635 shares at $50.43 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Exercised options 51,750 shares at $30.93 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 28, 2026Exercised options 431,904 shares at $10.36 of Kiniksa Pharmaceuticals International, plc⁹
• Apr 7, 2026Shares withheld for tax 4,831 shares at $48.94 of Kiniksa Pharmaceuticals International, plc¹⁰
• Apr 7, 2026Exercised options 9,991 shares of Kiniksa Pharmaceuticals International, plc¹⁰